These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20579988)

  • 1. Insurance mandates, embryo transfer, outcomes--the link is tenuous.
    Banks NK; Norian JM; Bundorf MK; Henne MB
    Fertil Steril; 2010 Dec; 94(7):2776-9. PubMed ID: 20579988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insurance mandates and trends in infertility treatments.
    Henne MB; Bundorf MK
    Fertil Steril; 2008 Jan; 89(1):66-73. PubMed ID: 17482603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut.
    Crawford S; Boulet SL; Jamieson DJ; Stone C; Mullen J; Kissin DM
    Fertil Steril; 2016 Feb; 105(2):347-55. PubMed ID: 26515377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States.
    Peipert BJ; Chung EH; Harris BS; Jain T
    Am J Obstet Gynecol; 2022 Jul; 227(1):64.e1-64.e8. PubMed ID: 35283088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of competition on assisted reproductive technology outcomes.
    Henne MB; Bundorf MK
    Fertil Steril; 2010 Apr; 93(6):1820-30. PubMed ID: 18442821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States.
    Stern JE; Cedars MI; Jain T; Klein NA; Beaird CM; Grainger DA; Gibbons WE;
    Fertil Steril; 2007 Aug; 88(2):275-82. PubMed ID: 17445805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry.
    ;
    Fertil Steril; 2007 Jun; 87(6):1253-66. PubMed ID: 17276436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study.
    Stern JE; Goldman MB; Hatasaka H; MacKenzie TA; Racowsky C; Surrey ES;
    Fertil Steril; 2009 Jan; 91(1):157-66. PubMed ID: 18222441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of embryo wastage with use of assisted reproductive technology: a look at the trends between 1995 and 2001 in the United States.
    Kovalevsky G; Patrizio P
    Fertil Steril; 2005 Aug; 84(2):325-30. PubMed ID: 16084872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States.
    Jain T; Missmer SA; Hornstein MD
    N Engl J Med; 2004 Apr; 350(16):1639-45. PubMed ID: 15084696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance coverage and outcomes of in vitro fertilization.
    Jain T; Harlow BL; Hornstein MD
    N Engl J Med; 2002 Aug; 347(9):661-6. PubMed ID: 12200554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assisted reproductive technologies (ART) in Canada: 2006 results from the Canadian ART Register.
    Gunby J; Bissonnette F; Librach C; Cowan L;
    Fertil Steril; 2010 May; 93(7):2189-201. PubMed ID: 19439295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study.
    Stern JE; Goldman MB; Hatasaka H; MacKenzie TA; Surrey ES; Racowsky C;
    Fertil Steril; 2009 Mar; 91(3):767-76. PubMed ID: 18321489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice patterns and outcomes with the use of single embryo transfer in the United States.
    Luke B; Brown MB; Grainger DA; Cedars M; Klein N; Stern JE;
    Fertil Steril; 2010 Feb; 93(2):490-8. PubMed ID: 19376512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of insurance mandates on donor oocyte utilization: an analysis of 39,338 donor oocyte cycles from the Society for Assisted Reproductive Technology registry.
    George JS; Lee MS; Ashby RK; Goldman R; Ginsburg ES; Lanes A; Srouji SS
    Am J Obstet Gynecol; 2022 Dec; 227(6):877.e1-877.e11. PubMed ID: 35863456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertility insurance mandates and multiple births.
    Buckles KS
    Health Econ; 2013 Jul; 22(7):775-89. PubMed ID: 22692947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of retained embryos on the outcome of assisted reproductive technologies.
    Lee HC; Seifer DB; Shelden RM
    Fertil Steril; 2004 Aug; 82(2):334-7. PubMed ID: 15302280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryo transfer practices and perinatal outcomes by insurance mandate status.
    Boulet SL; Crawford S; Zhang Y; Sunderam S; Cohen B; Bernson D; McKane P; Bailey MA; Jamieson DJ; Kissin DM;
    Fertil Steril; 2015 Aug; 104(2):403-9.e1. PubMed ID: 26051096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of legislation on outcomes of assisted reproduction technology: lessons from the 2004 Italian law.
    La Sala GB; Villani MT; Nicoli A; Valli B; Iannotti F; Blickstein I
    Fertil Steril; 2008 Apr; 89(4):854-9. PubMed ID: 17681340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to assisted reproductive technology centers in the United States.
    Nangia AK; Likosky DS; Wang D
    Fertil Steril; 2010 Feb; 93(3):745-61. PubMed ID: 19081563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.